Ticker
TVRDCompany Name
TVARDI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 396K | 6.02% | $ 6.58M |
3/31/2025 | $ 647K | 8.55% | $ 7.57M |
12/31/2024 | $ 958K | 13.42% | $ 7.14M |
9/30/2024 | $ 1.89M | 21.81% | $ 8.69M |
6/30/2024 | $ 2.1M | 19.11% | $ 11M |
3/31/2024 | $ 2.21M | 13.06% | $ 16.94M |
12/31/2023 | $ 2.33M | 11.13% | $ 20.97M |
9/30/2023 | $ 1.83M | 8.6% | $ 21.23M |
6/30/2023 | $ 1.73M | 6.35% | $ 27.17M |
3/31/2023 | $ 1.7M | 3.92% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor / Revenues
(=) DepAmor %
DepAmor % for TVARDI THERAPEUTICS INC is calculated as follows: DepAmor [ $ 847K ] / Revenues [ $ 27.5M ]
(=) DepAmor % [ 3.08% ]
Minimum
Dec 31, 2020
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.31K |
---|---|
min | -6.41% |
max | 22.51% |
average | 5.84% |
median | 4.22% |
std | 5.11% |